Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study

Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been studied as predictors for severe COVID-19 outcomes. The aim of the present study is to identify prognostic cut-off values of NLR and PLR for intubation and death in hospitalized COVID-19 patients, with or without i...

Full description

Saved in:
Bibliographic Details
Main Authors: Amalia Papanikolopoulou, Vasiliki Rapti, Polyxeni Alexiou, Charalampos M. Charalampous, Maria Effrosyni Livanou, Vissaria Sakka, Konstantinos N. Syrigos, Garyfallia Poulakou
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/14/6/550
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849425192226390016
author Amalia Papanikolopoulou
Vasiliki Rapti
Polyxeni Alexiou
Charalampos M. Charalampous
Maria Effrosyni Livanou
Vissaria Sakka
Konstantinos N. Syrigos
Garyfallia Poulakou
author_facet Amalia Papanikolopoulou
Vasiliki Rapti
Polyxeni Alexiou
Charalampos M. Charalampous
Maria Effrosyni Livanou
Vissaria Sakka
Konstantinos N. Syrigos
Garyfallia Poulakou
author_sort Amalia Papanikolopoulou
collection DOAJ
description Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been studied as predictors for severe COVID-19 outcomes. The aim of the present study is to identify prognostic cut-off values of NLR and PLR for intubation and death in hospitalized COVID-19 patients, with or without immunosuppression. From June 2021 to December 2022, we retrospectively analyzed 393 consecutively admitted COVID-19 patients, who were divided in two cohorts according to immunosuppression status (hematological malignancy and/or autoimmune condition vs. non-immunocompromised), using a propensity score-matching in 1:2 ratio. Higher NLR and PLR values were observed on days 1 and 4 for severe COVID-19, irrespective of immunosuppression status. NLR on day 1 >5.06 and day 4 >6.40 (<i>p</i> < 0.001), as well as PLR on day 1 >262.2 and day 4 >217.3 (<i>p</i> = 0.003), were associated with a greater probability for intubation. Similarly, a higher probability for death was found in the subset of patients with NLR on day 1 >4.82 (<i>p</i> < 0.001) and day 4 >6.41 (<i>p</i> < 0.001) and PLR on day 1 >229 (<i>p</i> = 0.009) and day 4 >205.4 (<i>p</i> = 0.003). Both PLR and NLR exhibited consistently higher negative predictive values (NPVs) (>93%) compared to positive predictive values (PPVs) for intubation and death. NLR and PLR displayed strong prognostic potential in hospitalized COVID-19 patients regarding intubation and death, irrespective of immunosuppression status, thus the surveillance of these biomarkers may help clinicians identify high-risk COVID-19 patients at an early stage.
format Article
id doaj-art-53d45e9b7b414f9f8d0156112ec7983d
institution Kabale University
issn 2076-0817
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj-art-53d45e9b7b414f9f8d0156112ec7983d2025-08-20T03:29:51ZengMDPI AGPathogens2076-08172025-06-0114655010.3390/pathogens14060550Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center StudyAmalia Papanikolopoulou0Vasiliki Rapti1Polyxeni Alexiou2Charalampos M. Charalampous3Maria Effrosyni Livanou4Vissaria Sakka5Konstantinos N. Syrigos6Garyfallia Poulakou7Third Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Internal Medicine and Laboratory, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceNeutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been studied as predictors for severe COVID-19 outcomes. The aim of the present study is to identify prognostic cut-off values of NLR and PLR for intubation and death in hospitalized COVID-19 patients, with or without immunosuppression. From June 2021 to December 2022, we retrospectively analyzed 393 consecutively admitted COVID-19 patients, who were divided in two cohorts according to immunosuppression status (hematological malignancy and/or autoimmune condition vs. non-immunocompromised), using a propensity score-matching in 1:2 ratio. Higher NLR and PLR values were observed on days 1 and 4 for severe COVID-19, irrespective of immunosuppression status. NLR on day 1 >5.06 and day 4 >6.40 (<i>p</i> < 0.001), as well as PLR on day 1 >262.2 and day 4 >217.3 (<i>p</i> = 0.003), were associated with a greater probability for intubation. Similarly, a higher probability for death was found in the subset of patients with NLR on day 1 >4.82 (<i>p</i> < 0.001) and day 4 >6.41 (<i>p</i> < 0.001) and PLR on day 1 >229 (<i>p</i> = 0.009) and day 4 >205.4 (<i>p</i> = 0.003). Both PLR and NLR exhibited consistently higher negative predictive values (NPVs) (>93%) compared to positive predictive values (PPVs) for intubation and death. NLR and PLR displayed strong prognostic potential in hospitalized COVID-19 patients regarding intubation and death, irrespective of immunosuppression status, thus the surveillance of these biomarkers may help clinicians identify high-risk COVID-19 patients at an early stage.https://www.mdpi.com/2076-0817/14/6/550SARS-CoV-2COVID-19neutrophil-to-lymphocyte ratio (NLR)platelet-to-lymphocyte ratio (PLR)prognostic markerintubation
spellingShingle Amalia Papanikolopoulou
Vasiliki Rapti
Polyxeni Alexiou
Charalampos M. Charalampous
Maria Effrosyni Livanou
Vissaria Sakka
Konstantinos N. Syrigos
Garyfallia Poulakou
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
Pathogens
SARS-CoV-2
COVID-19
neutrophil-to-lymphocyte ratio (NLR)
platelet-to-lymphocyte ratio (PLR)
prognostic marker
intubation
title Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
title_full Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
title_fullStr Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
title_full_unstemmed Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
title_short Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
title_sort neutrophil to lymphocyte ratio nlr and platelet to lymphocyte ratio plr as prognostic markers of covid 19 disease irrespective of immunosuppression status a case control retrospective single center study
topic SARS-CoV-2
COVID-19
neutrophil-to-lymphocyte ratio (NLR)
platelet-to-lymphocyte ratio (PLR)
prognostic marker
intubation
url https://www.mdpi.com/2076-0817/14/6/550
work_keys_str_mv AT amaliapapanikolopoulou neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy
AT vasilikirapti neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy
AT polyxenialexiou neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy
AT charalamposmcharalampous neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy
AT mariaeffrosynilivanou neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy
AT vissariasakka neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy
AT konstantinosnsyrigos neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy
AT garyfalliapoulakou neutrophiltolymphocyterationlrandplatelettolymphocyteratioplrasprognosticmarkersofcovid19diseaseirrespectiveofimmunosuppressionstatusacasecontrolretrospectivesinglecenterstudy